4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-25-083048
Chief Medical Officer sold 1,342 shares at $13.35 ($17,916)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kerr Douglas Chief Medical Officer | 2025-06-05 | Sale 10b5-1 | −1,342 | $13.35 | $17,916 | 92,815 | D |
| Open-market sales · 1,342 sh · avg $13.35 · $17,916 | |||||||
Loading xslF345X05/ownership.xml…